scientific and microscope

Our clinical studies

We are committed to make our Clinical trials Information and Results accessible and transparent while maintaining participants privacy.

 

Clinical studies

This site provides information on both ongoing and completed clinical trials sponsored by Pierre Fabre since 2004. Real-world evidence studies which began after 01 January 2020 are also accessible.

 

Total studies

0

Current studies

0

Oncology

0

Dermatology

0

Rare diseases

0

Others

0
Show more filters
Title Therapeutic area Phase Status Start date (Planned) End date

Study of efficacy and safety of V0498 versus placebo in acute sore throat pain

Respiratory Phase III Completed February 13, 2013 June 25, 2013

Emollients in the management of atopic dermatitis in children: prevention of flares

Dermatology Phase III Completed February 07, 2013 February 12, 2014

Clinical and biophysics evaluation of the cutaneous modifications following the local use of a lotion containing 0,1 % of trétinoïne

Dermatology Phase IV Completed February 2013 February 20, 2014

Phase II trial of oral vinorelbine in Locally Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) patients with Epidermal Growth Factor Receptor (EGFR) positive mutation after failure or resistance to treatment with Tyrosine Kinase Inhibitors (TKI) in first line

Oncology Phase II Completed December 01, 2012 April 17, 2015

Randomised phase II trial of oral vinorelbine and cisplatin followed by maintenance with single agent oral vinorelbine versus gemcitabine and cisplatin followed by maintenance with single agent gemcitabine in first line Locally Advanced or Metastatic Non-Small-Cell Lung Cancer patients with squamous histological type

Oncology Phase II Completed December 01, 2012 May 19, 2017

Randomised phase II study evaluating, as first-line chemotherapy, weekly oral vinorelbine as a single-agent versus weekly paclitaxel as a single-agent in estrogen receptor positive, HER2 negative patients with advanced breast cancer

Oncology Phase II Completed October 04, 2012 September 05, 2018

Exploratory study of L.S.E.S.r. (PERMIXON® 160 mg hard capsule) versus Tamsulosine LP activity on inflammation biomarkers in the treatment of urinary symptoms related to BPH, A multinational, multicen...

Urology Phase IV Completed June 27, 2012 October 08, 2013

Effect of 3-month treatment with F2695 (75mg OD) on improving functional recovery of patients with ischemic stroke. A multicenter, randomised, double-blind, parallel-group, placebo-controlled study

Cardiovascular Phase II Completed June 18, 2012 February 11, 2015

Effect of V0251 in acute vertigo. A randomized double blind placebo conrolled study

Central Nervous System Phase II Completed June 16, 2012 April 15, 2013

Phase III study of IV vinflunine in combination with methotrexate versus methotrexate alone in patients with recurrent or metastatic squamous cell carcinoma of the head and neck previously treated with platinum-based chemotherapy (study L00070 IN 309 F0)

Oncology Phase III Completed April 02, 2012 November 23, 2018

Analgesic profile of 3 new Ibuprofen lozenges (V0498TA01A 15mg, 25mg,

Central Nervous System Phase II Completed February 15, 2012 November 02, 2012

A randomised, double blind, controlled, multicentre study in infants with infantile hemangioma to compare propranolol gel to placebo

Dermatology Phase II Completed February 10, 2012 May 09, 2013

Efficacy of the V0034CR01B emollient on xerosis in children with atopic dermatitis. Randomised, vehicle-controlled, parallel-groups, double-blind study with an open label extension

Dermatology Phase III Completed November 30, 2011 May 24, 2012

Urodynamic effect of one single vaginal application of 2 mL of V0162 gel (0.8%) in post-menopausal women with overactive bladder

Urology Phase II Completed July 11, 2011 October 13, 2011

Phase II study assessing the maintenance treatment with vinflunine after first-line therapy with gemcitabine and cisplatin in patients with advanced or metastatic transitional cell carcinoma of the urothelial tract

Oncology Phase II Completed June 30, 2011 February 14, 2015

V0251 oral suspension efficacy and tolerance in vestibular neuritis. A randomised double-blind placebo controlled study

Central Nervous System Phase II Completed May 17, 2011 April 30, 2012

Effect of treatment with ossein-hydroxyapatite compound on the time of fracture-healing". A prospective, multicenter, double-blind, randomised, placebo controlled clinical trial

Muskuloskeletal Phase IV Completed April 17, 2011 June 20, 2012

Randomized phase II study assessing the combination of Vinflunine with Gemcitabine and Vinflunine with Carboplatin in patients ineligible to cisplatin with advanced or metastatic transitional cell carcinoma of the urothelium

Oncology Phase II Completed October 05, 2010 November 22, 2010

A phase II multicentric study in adults with acute myelogenous leukaemia (AML) in first complete remission (CR1) using IV BuCy2 in a once daily Bu regimen targeting a narrow therapeutic window prior t...

Oncology Phase II Completed May 17, 2010 June 19, 2014

Phase II study evaluating oral vinorelbine as a single agent in patients with hormone receptor breast cancer with bone metastases previously treated by a hormone therapy

Oncology Phase II Completed April 10, 2010 June 17, 2015

Get access to Partner's pivotal studies supporting our authorized drugs in Europe

Results from pivotal studies conducted by our partners and supporting a marketing approval for whom Pierre Fabre is the holder in Europe are shared below:

 

Melanoma

SPONSOR: PFIZER

Breast cancer 

SPONSOR: PUMA BIOTECHNOLOGY

Colorectal cancer

SPONSOR: PFIZER

Post-transplantation lymphoproliferative disease EBV+

SPONSOR: ATARA